SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001157523-09-008707
Filing Date
2009-12-21
Accepted
2009-12-21 15:16:11
Documents
5
Period of Report
2009-10-31

Document Format Files

Seq Description Document Type Size
1 LIGHTLAKE THERAPEUTICS INC. 10-Q a6125421.txt 10-Q 35512
2 EXHIBIT 31.1 a6125421ex31_1.txt EX-31.1 4347
3 EXHIBIT 31.2 a6125421ex31_2.txt EX-31.2 4297
4 EXHIBIT 32.1 a6125421ex32_1.txt EX-32.1 1961
5 EXHIBIT 32.2 a6125421ex32_2.txt EX-32.2 1911
  Complete submission text file 0001157523-09-008707.txt   49532
Mailing Address 225-230 QUEENS QUAY W. TORONTO A6 M5J 2Y7
Business Address 225-230 QUEENS QUAY W. TORONTO A6 M5J 2Y7 416-841-5414
Lightlake Therapeutics Inc. (Filer) CIK: 0001385508 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 333-139915 | Film No.: 091252304
SIC: 1000 Metal Mining